57894-0240 LAZCLUZE - CanMED: NDC

Product NDC:

57894-0240

Brand Name:

LAZCLUZE

Generic Name:

Lazertinib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: LAZERTINIB

Strength: 240.0

Unit: mg/1

Packages:

Code: 57894-0240-30

Description: 1 BOTTLE in 1 CARTON (57894-240-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Effective Date: Aug. 20, 2024

Discontinued:

Code: 57894-0240-99

Description: 1 DOSE PACK in 1 CARTON (57894-240-99) / 14 TABLET, FILM COATED in 1 DOSE PACK

Effective Date: Aug. 20, 2024

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

EGFR

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox